Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
  1. 4 Grant or award Chief Legal Officer acquired 42,403 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Option exercise SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,000 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Chief Medical Officer sold 2,151 shares at $41.98 ($90,307)
  7. 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 3,117 shares at $41.98 ($130,864)
  8. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 4,949 shares at $41.98 ($207,778)
  9. 4 Open-market sale PRESIDENT AND CEO sold 16,925 shares at $41.98 ($710,578)
  10. 4 Open-market sale Chief Operating Officer sold 2,579 shares at $41.98 ($108,276)
  11. 4 Open-market sale Chief Regulatory Officer sold 2,187 shares at $41.98 ($91,819)
  12. 4 Open-market sale Chief Commercial Officer sold 1,582 shares at $41.98 ($66,419)
  13. 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,000 shares (grant or award)
  14. 4 Grant or award PRESIDENT AND CEO acquired 68,800 shares (grant or award)
  15. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
  16. 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
  17. 4 Grant or award Chief Regulatory Officer acquired 25,000 shares (grant or award)
  18. 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 25,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 2 of 12 · 230 filings